|
|||||
|
|
External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population |
|
| Authors: | Terzikhan Natalie Hofman Albert Goudsmit Jaap Ikram Mohammad Arfan |
| Affiliation: | 1.Department of Epidemiology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands ;2.Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA ;3.Human Immunomics Initiative, Department of Epidemiology, Harvard T.H. Chan School of Public Health and Human Vaccines Project, Boston, MA, USA ;4.Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA ; |
| Abstract: | European Journal of Epidemiology - Initial results from various phase-III trials on vaccines against SARS-CoV-2 are promising. For proper translation of these results to clinical guidelines, it is... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |